Prevention of diabetes, hepatic injury, and colon cancer with dehydroepiandrosterone

Journal of Steroid Biochemistry and Molecular Biology

Volumn 85, Issue 2-5, 2003, Pages 469-472

  Aoki, Kazutaka ^a   Nakajima, Atsushi ^a   Mukasa, Koji ^a   Osawa, Emi ^a   Mori, Yasumichi ^a   Sekihara, Hisahiko ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Dehydroepiandrosterone (DHEA); Diabetes; Troglitazone

Indexed keywords

AZOXYMETHANE; GLUCOSE 6 PHOSPHATASE; INSULIN; LIVER ENZYME; PRASTERONE; RECOMBINANT HORMONE; RECOMBINANT PRASTERONE; TROGLITAZONE; UNCLASSIFIED DRUG;

AGING; APOPTOSIS; CHEMOPROPHYLAXIS; COLON ADENOMA; COLON CANCER; CONFERENCE PAPER; DIABETES MELLITUS; ENZYME ACTIVITY; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE CLAMP TECHNIQUE; HEPATITIS; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER; LIVER INJURY; MUSCLE; NICK END LABELING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ANIMALIA; MURINAE;

EID: 0041386392     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(03)00219-X     Document Type: Conference Paper

References (21)

1. Aoki K., Homma M., Hirano T., Oka K., Satoh S., Mukasa K., Ito S., Sekihara H. mRNA and enzymatic activity of hepatic 11 beta-hydroxysteroid dehydrogenase type 1 are elevated in C57BL/KsJ-db/db mice. Life Sci. 69:2001;2543-2549.
2. Gunnarsson R. Function of the pancreatic B-cell during the development of hyperglycemia in mice homozygous for the mutations "diabetes" (db) and "misty" (m). Diabetologia. 11:1975;431-438.
3. Coleman D.L., Leiter E.H., Schwizer R.W. Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes. 31:1982;830-833.
4. Coleman D.L., Schwizer R.W., Leiter E.H. Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetes-obesity mutants and aged normal mice. Diabetes. 33:1984;26-32.
5. Ladriere L., Laghmich A., Malaisse-Lagae F., Malaisse W.J. Effect of dehydroepiandrosterone in hereditarily diabetic rats. Cell Biochem. Funct. 15:1997;287-292.
6. Kimura M., Tanaka S., Yamada Y., Kikuchi Y., Yamakawa T., Sekihara H. Dehydroepiandrosterone decreases serum TNF α and restores insulin sensitivity: independent effect from secondary weight reduction in genetically obese Zucker fatty rats. Endocrinology. 139:1998;3249-3253.
7. Mukasa K., Kaneshiro M., Aoki K., Okamura J., Saito T., Satoh S., Sekihara H. Dehydroepiandrosterone (DHEA) ameliorates the insulin sensitivity in older rats. J. Steroid Biochem. Mol. Biol. 67:1998;355-358.
8. Lasco A., Frisina N., Morabito N., Gaudio A., Morini E., Trifiletti A., Basile G., Nicita-Mauro V., Cucinotta D. Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women. Eur. J. Endocrinol. 145:2001;457-461.
9. Ishizawa M., Ishizuka T., Kajita K., Miura A., Kanoh Y., Kimura M., Yasuda K. Dehydroepiandrosterone (DHEA) stimulates glucose uptake in rat adipocytes: activation of phospholipase D. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 130:2001;359-364.
10. Pilkis S.J., Granner D.K. Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu. Rev. Physiol. 54:1992;885-909.
11. Aoki K., Saito T., Mukasa K., Kaneshiro M., Kawasaki S., Okamura A., Sekihara H. Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phosphatase and fructose-1,6-bisphosphatase activities in C57BL/KsJ-db/db mice: comparison with troglitazone. Diabetes. 48:1999;1579-1585.
12. Aoki K., Kikuchi T., Mukasa K., Itoh S., Nakajima A., Satoh S., Okamura A., Sekihara H. Dehydroepiandrosterone suppresses elevated hepatic glucose-6-phosphatase mRNA level in C57BL/KsJ-db/db mice: comparison with troglitazone. Endocrinol. J. 47:2000;799-804.
13. McIntosh M.K., Berdanier C.D. Antiobesity effects of dehydroepiandrosterone are mediated by futile substrate cycling in hepatocytes of BHE/cbd Rats. J. Nutr. 121:1991;2037-2043.
14. Dillon J.S., Yaney G.C., Zhou Y., Voilley N., Bowen S., Chipkin S., Bliss C.R., Schultz V., Schuit F.C., Prentki M., Waxman D.J., Corkey B.E. Dehydroepiandrosterone sulfate and beta-cell function: enhanced glucose-induced insulin secretion and altered gene expression in rodent pancreatic beta-cells. Diabetes. 49:2000;2012-2020.
15. Fink R.I., Kolterman O.G., Griffin J., Olefsky J.M. Mechanisms of insulin resistance in aging. J. Clin. Invest. 71:1983;1523-1535.
16. Nestler J.E., Clore J.N., Strauss J.F., Blackard W.G. The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans. J. Clin. Endocrinol. Metab. 64:1987;180-184.
17. Nestler J.E., Beer N.A., Jakubowicz D.J., Colombo C., Beer R.M. Effects of insulin reduction with benfluorex on serum dehydroepiandrosterone (DHEA), DHEA sulfate, and blood pressure in hypertensive middle-aged and elderly men. J. Clin. Endocrinol. Metab. 80:1995;700-706.
18. Yamaguchi Y., Tanaka S., Yamakawa T., Kimura M., Ukawa K., Yamada Y., Ishihara M., Sekihara H. Reduced serum dehydroepiandrosterone levels in diabetic patients with hyperinsulinemia. Clin. Endocrinol. (Oxford). 49:1998;377-383.
19. S. Yoshida, A. Nakajima, K. Mukasa, M. Omura, K. Nagashima, K. Wada, H. Sekihara, Dehydroepiandrosterone (DHEA) as a novel therapeutic agent for acute hepatic injury, In: Proceedings of the Endocrine Society's 83rd Annual Meeting Program and Abstracts, 2001, p. 422.
20. Osawa E., Nakajima A., Yoshida S., Omura M., Nagase H., Ueno N., Wada K., Matsuhashi N., Ochiai M., Nakagama H., Sekihara H. Chemoprevention of precursors to colon cancer by dehydroepiandrosterone (DHEA). Life Sci. 19(70):2002;2623-2630.
21. Nyce J.W., Magee P.N., Hard G.C., Schwartz A.G. Inhibition of 1,2-dimethylhydrazine-induced colon tumorigenesis in Balb/c mice by dehydroepiandrosterone. Carcinogenesis. 5:1984;57-62.